nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofibrate—CYP1A1—Clobetasol propionate—psoriasis	0.169	0.19	CbGbCtD
Clofibrate—CYP4A11—Dexamethasone—psoriasis	0.139	0.157	CbGbCtD
Clofibrate—CYP2A6—Methoxsalen—psoriasis	0.104	0.117	CbGbCtD
Clofibrate—CYP1A1—Methoxsalen—psoriasis	0.0885	0.0998	CbGbCtD
Clofibrate—CYP1A1—Cholecalciferol—psoriasis	0.0586	0.0661	CbGbCtD
Clofibrate—CYP2A6—Prednisolone—psoriasis	0.0504	0.0568	CbGbCtD
Clofibrate—CYP2B6—Cholecalciferol—psoriasis	0.0447	0.0504	CbGbCtD
Clofibrate—CYP2A6—Dexamethasone—psoriasis	0.0297	0.0335	CbGbCtD
Clofibrate—CYP3A4—Calcitriol—psoriasis	0.0266	0.03	CbGbCtD
Clofibrate—CYP1A1—Dexamethasone—psoriasis	0.0254	0.0286	CbGbCtD
Clofibrate—CYP3A4—Methoxsalen—psoriasis	0.0207	0.0234	CbGbCtD
Clofibrate—CYP2E1—Dexamethasone—psoriasis	0.0196	0.0221	CbGbCtD
Clofibrate—CYP2B6—Dexamethasone—psoriasis	0.0193	0.0218	CbGbCtD
Clofibrate—CYP3A4—Cholecalciferol—psoriasis	0.0137	0.0155	CbGbCtD
Clofibrate—CYP3A4—Triamcinolone—psoriasis	0.0119	0.0134	CbGbCtD
Clofibrate—CYP3A4—Mycophenolate mofetil—psoriasis	0.0119	0.0134	CbGbCtD
Clofibrate—CYP3A4—Betamethasone—psoriasis	0.0102	0.0115	CbGbCtD
Clofibrate—CYP3A4—Prednisolone—psoriasis	0.0101	0.0114	CbGbCtD
Clofibrate—CYP3A4—Hydrocortisone—psoriasis	0.00955	0.0108	CbGbCtD
Clofibrate—CYP3A4—Prednisone—psoriasis	0.00951	0.0107	CbGbCtD
Clofibrate—CYP3A4—Cyclosporine—psoriasis	0.00902	0.0102	CbGbCtD
Clofibrate—CYP4A11—Miscellaneous substrates—CYP2S1—psoriasis	0.00777	0.0695	CbGpPWpGaD
Clofibrate—CYP3A4—Dexamethasone—psoriasis	0.00594	0.0067	CbGbCtD
Clofibrate—CYP2A6—CYP2E1 reactions—CYP2S1—psoriasis	0.00444	0.0397	CbGpPWpGaD
Clofibrate—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.00358	0.032	CbGpPWpGaD
Clofibrate—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.00351	0.0313	CbGpPWpGaD
Clofibrate—CYP2A6—Xenobiotics—CYP2S1—psoriasis	0.00275	0.0246	CbGpPWpGaD
Clofibrate—PPARA—REV-ERBA represses gene expression—CARM1—psoriasis	0.00245	0.0219	CbGpPWpGaD
Clofibrate—PPARA—RORA activates circadian gene expression—CARM1—psoriasis	0.00237	0.0212	CbGpPWpGaD
Clofibrate—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.00222	0.0198	CbGpPWpGaD
Clofibrate—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00217	0.0194	CbGpPWpGaD
Clofibrate—CYP4A11—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00214	0.0192	CbGpPWpGaD
Clofibrate—CYP4A11—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00212	0.0189	CbGpPWpGaD
Clofibrate—PPARA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—CARM1—psoriasis	0.0021	0.0188	CbGpPWpGaD
Clofibrate—CYP1A1—Xenobiotics—CYP2S1—psoriasis	0.00205	0.0183	CbGpPWpGaD
Clofibrate—CYP4A11—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00174	0.0155	CbGpPWpGaD
Clofibrate—PPARA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	0.00173	0.0155	CbGpPWpGaD
Clofibrate—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.00171	0.0153	CbGpPWpGaD
Clofibrate—PPARA—Activation of gene expression by SREBF (SREBP)—CARM1—psoriasis	0.00162	0.0145	CbGpPWpGaD
Clofibrate—GSTA2—Biological oxidations—CYP2S1—psoriasis	0.00154	0.0137	CbGpPWpGaD
Clofibrate—PPARA—Transcriptional activation of mitochondrial biogenesis—CARM1—psoriasis	0.00148	0.0132	CbGpPWpGaD
Clofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.00137	0.0122	CbGpPWpGaD
Clofibrate—Bezafibrate—PPARG—psoriasis	0.00135	1	CrCbGaD
Clofibrate—PPARA—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CARM1—psoriasis	0.0013	0.0116	CbGpPWpGaD
Clofibrate—PPARA—Mitochondrial biogenesis—CARM1—psoriasis	0.00128	0.0114	CbGpPWpGaD
Clofibrate—PPARA—Circadian Clock—CARM1—psoriasis	0.00126	0.0113	CbGpPWpGaD
Clofibrate—PPARA—Estrogen Receptor Pathway—JUN—psoriasis	0.00118	0.0105	CbGpPWpGaD
Clofibrate—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00114	0.0102	CbGpPWpGaD
Clofibrate—CYP2A6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00113	0.0101	CbGpPWpGaD
Clofibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.0011	0.00988	CbGpPWpGaD
Clofibrate—PPARA—Estrogen Receptor Pathway—STAT3—psoriasis	0.00102	0.00912	CbGpPWpGaD
Clofibrate—PPARA—Nuclear Receptors—VDR—psoriasis	0.00101	0.00904	CbGpPWpGaD
Clofibrate—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.00101	0.00901	CbGpPWpGaD
Clofibrate—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000985	0.0088	CbGpPWpGaD
Clofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—CARM1—psoriasis	0.000962	0.0086	CbGpPWpGaD
Clofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.000955	0.00854	CbGpPWpGaD
Clofibrate—CYP2A6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000926	0.00828	CbGpPWpGaD
Clofibrate—CYP4A11—Biological oxidations—CYP2S1—psoriasis	0.000923	0.00825	CbGpPWpGaD
Clofibrate—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000921	0.00824	CbGpPWpGaD
Clofibrate—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000909	0.00813	CbGpPWpGaD
Clofibrate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000902	0.00807	CbGpPWpGaD
Clofibrate—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000891	0.00796	CbGpPWpGaD
Clofibrate—GSTA2—NRF2 pathway—TGFA—psoriasis	0.000855	0.00765	CbGpPWpGaD
Clofibrate—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000851	0.00761	CbGpPWpGaD
Clofibrate—CYP1A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00084	0.00751	CbGpPWpGaD
Clofibrate—PPARA—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000799	0.00714	CbGpPWpGaD
Clofibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00077	0.00689	CbGpPWpGaD
Clofibrate—PPARA—Orphan transporters—CARM1—psoriasis	0.000757	0.00676	CbGpPWpGaD
Clofibrate—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000747	0.00668	CbGpPWpGaD
Clofibrate—GSTA2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000736	0.00658	CbGpPWpGaD
Clofibrate—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000732	0.00654	CbGpPWpGaD
Clofibrate—PPARA—PPARA activates gene expression—CARM1—psoriasis	0.000723	0.00647	CbGpPWpGaD
Clofibrate—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.000715	0.00639	CbGpPWpGaD
Clofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000708	0.00633	CbGpPWpGaD
Clofibrate—PPARA—Nuclear Receptors—PPARG—psoriasis	0.000705	0.0063	CbGpPWpGaD
Clofibrate—CYP1A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00069	0.00617	CbGpPWpGaD
Clofibrate—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000687	0.00614	CbGpPWpGaD
Clofibrate—CYP4A11—PPARA activates gene expression—CARM1—psoriasis	0.000645	0.00576	CbGpPWpGaD
Clofibrate—GSTA2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000636	0.00569	CbGpPWpGaD
Clofibrate—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000631	0.00564	CbGpPWpGaD
Clofibrate—PPARA—Organelle biogenesis and maintenance—CARM1—psoriasis	0.00058	0.00518	CbGpPWpGaD
Clofibrate—PPARA—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000557	0.00498	CbGpPWpGaD
Clofibrate—CYP4A11—NRF2 pathway—TGFA—psoriasis	0.000514	0.0046	CbGpPWpGaD
Clofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000507	0.00453	CbGpPWpGaD
Clofibrate—CYP2A6—Biological oxidations—CYP2S1—psoriasis	0.000492	0.0044	CbGpPWpGaD
Clofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000488	0.00436	CbGpPWpGaD
Clofibrate—GSTA2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.000476	0.00426	CbGpPWpGaD
Clofibrate—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.000474	0.00424	CbGpPWpGaD
Clofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—LEP—psoriasis	0.00046	0.00411	CbGpPWpGaD
Clofibrate—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000456	0.00408	CbGpPWpGaD
Clofibrate—CYP1A1—Oxidative Stress—CAT—psoriasis	0.000445	0.00398	CbGpPWpGaD
Clofibrate—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000435	0.00389	CbGpPWpGaD
Clofibrate—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000423	0.00378	CbGpPWpGaD
Clofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000419	0.00374	CbGpPWpGaD
Clofibrate—CYP1A1—Estrogen Receptor Pathway—JUN—psoriasis	0.000417	0.00373	CbGpPWpGaD
Clofibrate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000415	0.00371	CbGpPWpGaD
Clofibrate—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.000414	0.0037	CbGpPWpGaD
Clofibrate—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000413	0.00369	CbGpPWpGaD
Clofibrate—PPARA—Adipogenesis—SOCS1—psoriasis	0.00041	0.00366	CbGpPWpGaD
Clofibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000408	0.00365	CbGpPWpGaD
Clofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—PPARG—psoriasis	0.000401	0.00358	CbGpPWpGaD
Clofibrate—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000397	0.00355	CbGpPWpGaD
Clofibrate—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000391	0.0035	CbGpPWpGaD
Clofibrate—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000389	0.00347	CbGpPWpGaD
Clofibrate—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000383	0.00343	CbGpPWpGaD
Clofibrate—CYP1A1—Biological oxidations—CYP2S1—psoriasis	0.000366	0.00328	CbGpPWpGaD
Clofibrate—CYP1A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000361	0.00323	CbGpPWpGaD
Clofibrate—CYP1A1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000361	0.00323	CbGpPWpGaD
Clofibrate—CYP1A1—Melatonin metabolism and effects—APOE—psoriasis	0.000355	0.00318	CbGpPWpGaD
Clofibrate—PPARA—Gene Expression—TARS—psoriasis	0.000354	0.00316	CbGpPWpGaD
Clofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000339	0.00303	CbGpPWpGaD
Clofibrate—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000335	0.003	CbGpPWpGaD
Clofibrate—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000335	0.00299	CbGpPWpGaD
Clofibrate—CYP1A1—Tryptophan metabolism—CAT—psoriasis	0.000316	0.00283	CbGpPWpGaD
Clofibrate—GSTA2—Metabolism—NDUFA5—psoriasis	0.000309	0.00276	CbGpPWpGaD
Clofibrate—PPARA—Adipogenesis—LEP—psoriasis	0.000302	0.0027	CbGpPWpGaD
Clofibrate—PPARA—PPARA activates gene expression—PPARG—psoriasis	0.000301	0.00269	CbGpPWpGaD
Clofibrate—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000295	0.00264	CbGpPWpGaD
Clofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	0.000295	0.00263	CbGpPWpGaD
Clofibrate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000289	0.00258	CbGpPWpGaD
Clofibrate—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000274	0.00245	CbGpPWpGaD
Clofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—NFKB1—psoriasis	0.000273	0.00244	CbGpPWpGaD
Clofibrate—CYP4A11—PPARA activates gene expression—PPARG—psoriasis	0.000268	0.0024	CbGpPWpGaD
Clofibrate—PPARA—Adipogenesis—PPARG—psoriasis	0.000263	0.00236	CbGpPWpGaD
Clofibrate—GSTA2—Metabolism—CYP2S1—psoriasis	0.000263	0.00235	CbGpPWpGaD
Clofibrate—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	0.000263	0.00235	CbGpPWpGaD
Clofibrate—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	0.000256	0.00229	CbGpPWpGaD
Clofibrate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.00025	0.00224	CbGpPWpGaD
Clofibrate—PPARA—Generic Transcription Pathway—CARM1—psoriasis	0.000231	0.00207	CbGpPWpGaD
Clofibrate—PPARA—Developmental Biology—CARM1—psoriasis	0.000218	0.00194	CbGpPWpGaD
Clofibrate—PPARA—Circadian rythm related genes—LEP—psoriasis	0.000213	0.00191	CbGpPWpGaD
Clofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—TNF—psoriasis	0.000213	0.0019	CbGpPWpGaD
Clofibrate—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	0.000211	0.00189	CbGpPWpGaD
Clofibrate—PPARA—Metabolism—NDUFA5—psoriasis	0.000208	0.00186	CbGpPWpGaD
Clofibrate—CYP1A1—Oxidative Stress—NFKB1—psoriasis	0.000206	0.00184	CbGpPWpGaD
Clofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	0.000203	0.00182	CbGpPWpGaD
Clofibrate—PPARA—Circadian rythm related genes—NOS2—psoriasis	0.000199	0.00178	CbGpPWpGaD
Clofibrate—PPARA—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000194	0.00174	CbGpPWpGaD
Clofibrate—PPARA—Transmembrane transport of small molecules—CP—psoriasis	0.000194	0.00173	CbGpPWpGaD
Clofibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000192	0.00172	CbGpPWpGaD
Clofibrate—PPARA—Circadian rythm related genes—PPARG—psoriasis	0.000186	0.00166	CbGpPWpGaD
Clofibrate—CYP4A11—Metabolism—NDUFA5—psoriasis	0.000186	0.00166	CbGpPWpGaD
Clofibrate—PPARA—Transmembrane transport of small molecules—CARM1—psoriasis	0.000185	0.00165	CbGpPWpGaD
Clofibrate—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	0.000181	0.00162	CbGpPWpGaD
Clofibrate—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.00018	0.00161	CbGpPWpGaD
Clofibrate—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000178	0.00159	CbGpPWpGaD
Clofibrate—PPARA—Metabolism—CYP2S1—psoriasis	0.000177	0.00158	CbGpPWpGaD
Clofibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000176	0.00157	CbGpPWpGaD
Clofibrate—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	0.000175	0.00157	CbGpPWpGaD
Clofibrate—CYP4A11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000173	0.00155	CbGpPWpGaD
Clofibrate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000173	0.00154	CbGpPWpGaD
Clofibrate—PPARA—Adipogenesis—STAT3—psoriasis	0.000162	0.00145	CbGpPWpGaD
Clofibrate—CYP4A11—Metabolism—CYP2S1—psoriasis	0.000158	0.00141	CbGpPWpGaD
Clofibrate—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000156	0.00139	CbGpPWpGaD
Clofibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000152	0.00136	CbGpPWpGaD
Clofibrate—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000146	0.00131	CbGpPWpGaD
Clofibrate—PPARA—Adipogenesis—TNF—psoriasis	0.00014	0.00125	CbGpPWpGaD
Clofibrate—PPARA—Generic Transcription Pathway—VDR—psoriasis	0.000138	0.00123	CbGpPWpGaD
Clofibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000134	0.0012	CbGpPWpGaD
Clofibrate—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000133	0.00119	CbGpPWpGaD
Clofibrate—PPARA—Circadian rythm related genes—JUN—psoriasis	0.000132	0.00118	CbGpPWpGaD
Clofibrate—GSTA2—Metabolism—CARM1—psoriasis	0.000128	0.00115	CbGpPWpGaD
Clofibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.000114	0.00102	CbGpPWpGaD
Clofibrate—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	0.000114	0.00102	CbGpPWpGaD
Clofibrate—PPARA—Adipogenesis—IL6—psoriasis	0.000113	0.00101	CbGpPWpGaD
Clofibrate—PPARA—Gene Expression—CARM1—psoriasis	0.000111	0.000995	CbGpPWpGaD
Clofibrate—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	0.000107	0.000952	CbGpPWpGaD
Clofibrate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	0.000104	0.000932	CbGpPWpGaD
Clofibrate—PPARA—Developmental Biology—LEP—psoriasis	0.000104	0.000929	CbGpPWpGaD
Clofibrate—CYP2A6—Metabolism—NDUFA5—psoriasis	9.89e-05	0.000884	CbGpPWpGaD
Clofibrate—PPARA—Generic Transcription Pathway—PPARG—psoriasis	9.62e-05	0.00086	CbGpPWpGaD
Clofibrate—PPARA—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.28e-05	0.00083	CbGpPWpGaD
Clofibrate—PPARA—Developmental Biology—PPARG—psoriasis	9.05e-05	0.00081	CbGpPWpGaD
Clofibrate—PPARA—Circadian rythm related genes—TP53—psoriasis	8.7e-05	0.000778	CbGpPWpGaD
Clofibrate—PPARA—Metabolism—CARM1—psoriasis	8.65e-05	0.000773	CbGpPWpGaD
Clofibrate—CYP2A6—Metabolism—CYP2S1—psoriasis	8.41e-05	0.000752	CbGpPWpGaD
Clofibrate—CYP4A11—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.28e-05	0.00074	CbGpPWpGaD
Clofibrate—PPARA—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.09e-05	0.000723	CbGpPWpGaD
Clofibrate—CYP2B6—Metabolism—NDUFA5—psoriasis	7.98e-05	0.000713	CbGpPWpGaD
Clofibrate—PPARA—Circadian rythm related genes—IL6—psoriasis	7.97e-05	0.000712	CbGpPWpGaD
Clofibrate—PPARA—Developmental Biology—TYK2—psoriasis	7.93e-05	0.000709	CbGpPWpGaD
Clofibrate—GSTA2—Metabolism—CAT—psoriasis	7.89e-05	0.000706	CbGpPWpGaD
Clofibrate—CYP2E1—Metabolism—NDUFA5—psoriasis	7.82e-05	0.000699	CbGpPWpGaD
Clofibrate—CYP4A11—Metabolism—CARM1—psoriasis	7.71e-05	0.000689	CbGpPWpGaD
Clofibrate—CYP1A1—Metabolism—NDUFA5—psoriasis	7.37e-05	0.000659	CbGpPWpGaD
Clofibrate—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.21e-05	0.000644	CbGpPWpGaD
Clofibrate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	7.18e-05	0.000642	CbGpPWpGaD
Clofibrate—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.87e-05	0.000614	CbGpPWpGaD
Clofibrate—CYP2B6—Metabolism—CYP2S1—psoriasis	6.79e-05	0.000607	CbGpPWpGaD
Clofibrate—CYP2E1—Metabolism—CYP2S1—psoriasis	6.65e-05	0.000594	CbGpPWpGaD
Clofibrate—PPARA—Gene Expression—VDR—psoriasis	6.64e-05	0.000594	CbGpPWpGaD
Clofibrate—CYP1A1—Metabolism—CYP2S1—psoriasis	6.27e-05	0.00056	CbGpPWpGaD
Clofibrate—PPARA—Developmental Biology—NFKB1—psoriasis	6.18e-05	0.000553	CbGpPWpGaD
Clofibrate—GSTA2—Metabolism—APOE—psoriasis	6.13e-05	0.000548	CbGpPWpGaD
Clofibrate—PPARA—Developmental Biology—VEGFA—psoriasis	5.61e-05	0.000502	CbGpPWpGaD
Clofibrate—PPARA—Developmental Biology—STAT3—psoriasis	5.56e-05	0.000497	CbGpPWpGaD
Clofibrate—GSTA2—Metabolism—PPARG—psoriasis	5.34e-05	0.000478	CbGpPWpGaD
Clofibrate—PPARA—Metabolism—CAT—psoriasis	5.32e-05	0.000476	CbGpPWpGaD
Clofibrate—PPARA—Developmental Biology—TNF—psoriasis	4.81e-05	0.00043	CbGpPWpGaD
Clofibrate—CYP4A11—Metabolism—CAT—psoriasis	4.74e-05	0.000424	CbGpPWpGaD
Clofibrate—PPARA—Gene Expression—PPARG—psoriasis	4.63e-05	0.000414	CbGpPWpGaD
Clofibrate—PPARA—Metabolism—APOE—psoriasis	4.13e-05	0.00037	CbGpPWpGaD
Clofibrate—CYP2A6—Metabolism—CARM1—psoriasis	4.11e-05	0.000367	CbGpPWpGaD
Clofibrate—PPARA—Developmental Biology—IL6—psoriasis	3.88e-05	0.000347	CbGpPWpGaD
Clofibrate—CYP4A11—Metabolism—APOE—psoriasis	3.69e-05	0.000329	CbGpPWpGaD
Clofibrate—CYP3A4—Metabolism—NDUFA5—psoriasis	3.63e-05	0.000324	CbGpPWpGaD
Clofibrate—PPARA—Metabolism—PPARG—psoriasis	3.6e-05	0.000322	CbGpPWpGaD
Clofibrate—CYP2B6—Metabolism—CARM1—psoriasis	3.31e-05	0.000296	CbGpPWpGaD
Clofibrate—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.28e-05	0.000294	CbGpPWpGaD
Clofibrate—CYP2E1—Metabolism—CARM1—psoriasis	3.25e-05	0.00029	CbGpPWpGaD
Clofibrate—CYP4A11—Metabolism—PPARG—psoriasis	3.21e-05	0.000287	CbGpPWpGaD
Clofibrate—CYP3A4—Metabolism—CYP2S1—psoriasis	3.08e-05	0.000276	CbGpPWpGaD
Clofibrate—CYP1A1—Metabolism—CARM1—psoriasis	3.06e-05	0.000274	CbGpPWpGaD
Clofibrate—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.86e-05	0.000256	CbGpPWpGaD
Clofibrate—CYP2A6—Metabolism—CAT—psoriasis	2.53e-05	0.000226	CbGpPWpGaD
Clofibrate—CYP2B6—Metabolism—CAT—psoriasis	2.04e-05	0.000182	CbGpPWpGaD
Clofibrate—CYP2E1—Metabolism—CAT—psoriasis	2e-05	0.000178	CbGpPWpGaD
Clofibrate—CYP2A6—Metabolism—APOE—psoriasis	1.96e-05	0.000175	CbGpPWpGaD
Clofibrate—CYP1A1—Metabolism—CAT—psoriasis	1.88e-05	0.000168	CbGpPWpGaD
Clofibrate—CYP2A6—Metabolism—PPARG—psoriasis	1.71e-05	0.000153	CbGpPWpGaD
Clofibrate—CYP2B6—Metabolism—APOE—psoriasis	1.58e-05	0.000142	CbGpPWpGaD
Clofibrate—CYP2E1—Metabolism—APOE—psoriasis	1.55e-05	0.000139	CbGpPWpGaD
Clofibrate—CYP3A4—Metabolism—CARM1—psoriasis	1.51e-05	0.000135	CbGpPWpGaD
Clofibrate—CYP1A1—Metabolism—APOE—psoriasis	1.46e-05	0.000131	CbGpPWpGaD
Clofibrate—CYP2B6—Metabolism—PPARG—psoriasis	1.38e-05	0.000123	CbGpPWpGaD
Clofibrate—CYP2E1—Metabolism—PPARG—psoriasis	1.35e-05	0.000121	CbGpPWpGaD
Clofibrate—CYP1A1—Metabolism—PPARG—psoriasis	1.27e-05	0.000114	CbGpPWpGaD
Clofibrate—CYP3A4—Metabolism—CAT—psoriasis	9.26e-06	8.28e-05	CbGpPWpGaD
Clofibrate—CYP3A4—Metabolism—APOE—psoriasis	7.2e-06	6.43e-05	CbGpPWpGaD
Clofibrate—CYP3A4—Metabolism—PPARG—psoriasis	6.27e-06	5.6e-05	CbGpPWpGaD
